SCHEMBL6823762

SCHEMBL6823762

O=C(NC1CCN(CCCCOc2cccc3c2C(=O)/C(=C/CC2CC2)O3)CC1)c1ccc(Cl)cc1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 6/20 0.45
DRD3 P35462 6/20 0.45
DRD2 P14416 5/20 0.45
HTR7 P34969 4/20 0.44
HTR1A P08908 2/20 0.44
MCHR1 Q99705 1/20 0.39
ADRA1D P25100 1/20 0.39
ADRA1A P35348 1/20 0.39
ADRA1B P35368 1/20 0.39
SLC2A1 P11166 1/20 0.39
DRD4 P21917 1/20 0.39
MEN1 O00255 1/20 0.39
RAD52 P43351 1/20 0.39
UBE2N P61088 1/20 0.39
KMT2A Q03164 1/20 0.39
PAX8 Q06710 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6820569 0.92 HTR7 (0.55) HTR7HTR1AMCHR1DRD4
SCHEMBL6823928 0.92 HTR7 (0.55) HTR7HTR1AMCHR1DRD4
SCHEMBL6823394 0.92 HTR7 (0.45) HTR7HTR1ADRD4MEN1KMT2A
SCHEMBL6823555 0.92 HTR7 (0.45) HTR7HTR1ADRD4MEN1KMT2A
SCHEMBL6823893 0.92 HTR7 (0.45) HTR7HTR1ADRD4MEN1KMT2A
SCHEMBL6824327 0.88 HTR7 (0.42) HTR2ADRD2HTR7HTR1ADRD4
SCHEMBL6824547 0.88 HTR7 (0.42) HTR2ADRD2HTR7HTR1ADRD4
SCHEMBL6823876 0.83 HTR7 (0.46) HTR2ADRD3DRD2HTR7HTR1A
SCHEMBL6823760 0.82 HTR7 (0.45) HTR2ADRD3DRD2HTR7HTR1A
SCHEMBL6455348 0.80 HTR7 (0.49) HTR2ADRD3DRD2HTR7HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004076444-A2 NOVEL HYDROXYCOUMARANONE DERIVATIVES AS ANTITUMOR AND ANTIMETASTATIC F. HOFFMANN-LA ROCHE AG (CH) 2004-09-10 WO claimed
WO-2004076444-A2 NOVEL HYDROXYCOUMARANONE DERIVATIVES AS ANTITUMOR AND ANTIMETASTATIC F. HOFFMANN-LA ROCHE AG (CH) 2004-09-10 WO disclosed